Viewing data from:

NADOLOL

ANDA

NADOLOL | A207761 | ZYDUS PHARMACEUTICALS USA INC

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.3106

per ea

Lowest NADAC/Unit

$0.1825

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
68382073301NADOLOL 40 MG TABLET	$0.3106	EA	Generic	—	2026-06-17
68382073401NADOLOL 80 MG TABLET	$0.2645	EA	Generic	—	2026-06-17
68382073201NADOLOL 20 MG TABLET	$0.1825	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs1 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

FERMION OYNADOLOL

DMF 62471986

SIGNA SA DE CVNADOLOL USP

DMF 74261988

MATRIX PHARMACORP PRIVATE LTDNADOLOL USP

DMF 249682011

BIOPHORE INDIA PHARMACEUTICALS PVT LTDNADOLOL

DMF 317352017

SYNCHEM CHEMICALS PRIVATE LTDInactiveNADOLOL

DMF 111921994

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 20MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 28, 2017

No patent or exclusivity listings for this strength.

#002 — 40MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 28, 2017

#003 — 80MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 28, 2017